APA (7th ed.) Citation

Mira, F., Donato, S., Vaz, F., Madeira, F., Picoto, M., Mendes, A., . . . Carneiro, Â. (2026). Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study. Ophthalmology & Therapy, 1. https://doi.org/10.1007/s40123-026-01448-4

Chicago Style (17th ed.) Citation

Mira, Filipe, et al. "Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study." Ophthalmology & Therapy 2026: 1. https://doi.org/10.1007/s40123-026-01448-4.

MLA (9th ed.) Citation

Mira, Filipe, et al. "Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study." Ophthalmology & Therapy, 2026, p. 1, https://doi.org/10.1007/s40123-026-01448-4.